Skip to main content
. 2021 Sep 2;92(4):e2021178. doi: 10.23750/abm.v92i4.10962

Table 3.

Development of ERCP Pancreatitis in Indomethacin and Control Groups

EP (-) EP (+) Total p
n % n % n % 0.043
Indomethacin 31 96.9 1 3.1 32 100
Control 22 78.6 6 21.4 28 100
Total 53 88.3 7 11.7 60 100